4//SEC Filing
Centea Scott 4
Accession 0001567619-21-018407
CIK 0001275187other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:45 PM ET
Size
8.6 KB
Accession
0001567619-21-018407
Insider Transaction Report
Form 4
Centea Scott
SVP/GM, VIT
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-10-15−12,000→ 0 totalExercise: $16.77From: 2015-10-24Exp: 2024-10-24→ Common Stock (12,000 underlying) - Exercise/Conversion
Common Stock
2021-10-15$16.77/sh+12,000$201,240→ 58,244 total - Sale
Common Stock
2021-10-15$27.92/sh−12,000$335,040→ 46,244 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.85 to $27.99, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
- [F2]Options for one-fourth of the shares became exercisable on 10/24/2015, 10/24/2016, 10/24/2017 and 10/24/2018, respectively.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeother
Related Parties
1- filerCIK 0001823973
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:45 PM ET
- Size
- 8.6 KB